Browse by Journal Title

Article

A computational model for prediction of ferritin and haemoglobin levels in blood donors.
Paalvast, Y. and Moazzen, S. and Sweegers, M. and Hogema, B. and Janssen, M. and van den Hurk, K.
British Journal of Haematology 199 (1): 143-152. October 2022

A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
Hess, G. and Hüttmann, A. and Witzens-Harig, M. and Dreyling, M.H. and Keller, U. and Marks, R. and Ernst, T. and Pott, C. and Viardot, A. and Frontzek, F. and Trautmann, M. and Ruckes, C. and Deuster, O. and Rosenwald, A. and Theobald, M. and Lenz, G.
British Journal of Haematology 198 (3): 482-491. 1 April 2022

Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras, N. and Dahm, S. and Haberland, J. and Janz, M. and Emrich, K. and Kraywinkel, K. and Salama, A.
British Journal of Haematology 177 (2): 226-242. April 2017

Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease.
Kortüm, K.M. and Langer, C. and Monge, J. and Bruins, L. and Egan, J.B. and Zhu, Y.X. and Shi, C.X. and Jedlowski, P. and Schmidt, J. and Ojha, J. and Bullinger, L. and Liebisch, P. and Kull, M. and Champion, M.D. and Van Wier, S. and Ahmann, G. and Rasche, L. and Knop, S. and Fonseca, R. and Einsele, H. and Stewart, A.K. and Braggio, E.
British Journal of Haematology 168 (4): 507-510. February 2015

Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis.
Lietz, A. and Janz, M. and Sigvardsson, M. and Jundt, F. and Doerken, B. and Mathas, S.
British Journal of Haematology 137 (4): 342-348. May 2007

Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
Westermann, J. and Kopp, J. and van Lessen, A. and Hecker, A.C. and Baskaynak, G. and le Coutre, P. and Doehner, K. and Doehner, H. and Doerken, B. and Pezzutto, A.
British Journal of Haematology 137 (4): 297-306. May 2007

Simultaneous cytokine analysis by cytometric bead array for the detection of leukaemia-reactive T cells in patients with chronic myeloid leukaemia.
Westermann, J. and Lessen, A. and Schlimper, C. and Baskaynak, G. and Coutre, P. and Doerken, B. and Pezzutto, A.
British Journal of Haematology 132 : 32-35. January 2006

Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial.
Reich, G. and Cornely, O.A. and Sandherr, M. and Kubin, T. and Krause, S. and Einsele, H. and Thiel, E. and Bellaire, T. and Doerken, B. and Maschmeyer, G.
British Journal of Haematology 130 : 265-270. 1 July 2005

T cell recognition of bcr/abl in healthy donors and in patients with chronic myeloid leukaemia.
Westermann, J. and Schlimper, C. and Richter, G. and Mohm, J. and Doerken, B. and Pezzutto, A.
British Journal of Haematology 125 (2): 213-216. 1 April 2004

Filgrastim-induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purging.
Kreuzer, K.A. and Kluehs, C. and Baskaynak, G. and Movassaghi, K. and Doerken, B. and Le Coutre, P.
British Journal of Haematology 124 (2): 195-199. 1 January 2004

Alveolar rhabdomyosarcoma with bone marrow infiltration mimicking haematological neoplasia.
Maywald, O. and Metzgeroth, G. and Schoch, C. and Ludwig, W.D. and Neff, W. and Hehlmann, R. and Hastka, J.
British Journal of Haematology 119 : 583. 1 December 2002

Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias.
Kreuzer, K.A. and Saborowski, A. and Lupberger, J. and Appelt, C. and Na, I.K. and le Coutre, P. and Schmidt, C.A.
British Journal of Haematology 114 (2): 313-318. August 2001

Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2.
Hilgenfeld, E. and Padilla-Nash, H. and McNeil, N. and Knutsen, T. and Montagna, C. and Tchinda, J. and Horst, J. and Ludwig, W.D. and Serve, H. and Buechner, T. and Berdel, W.E. and Schroeck, E. and Ried, T.
British Journal of Haematology 113 : 305-317. 1 May 2001

Acute myeloid leukaemia MO: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients.
Bene, M.C. and Bernier, M. and Casasnovas, R.O. and Castoldi, G. and Doekharan, D. and van der Holt, B. and Knapp, W. and Lemez, P. and Ludwig, W.D. and Matutes, E. and Orfao, A. and Schoch, C. and Sperling, C. and van't Veer, M.B.
British Journal of Haematology 113 : 737-745. 1 January 2001

Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Wuchter, C. and Karawajew, L. and Ruppert, V. and Schrappe, M. and Harbott, J. and Ratei, R. and Doerken, B. and Ludwig, W.D.
British Journal of Haematology 110 : 154-160. 1 July 2000

Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia.
Beltinger, C. and Boehler, T. and Karawajew, L. and Ludwig, W.D. and Schrappe, M. and Debatin, K.M.
British Journal of Haematology 102 : 722-728. 1 August 1998

Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12.
Streubel, B. and Sauerland, C. and Heil, G. and Freund, M. and Bartels, H. and Lengfelder, E. and Wandt, H. and Ludwig, W.D. and Nowotny, H. and Baldus, M. and Grothaus-Pinke, B. and Buechner, T. and Fonatsch, C.
British Journal of Haematology 100 : 521-533. 1 March 1998

Immunophenotypic and clinical features of T-cell receptor gammadelta+ T-lineage acute lymphoblastic leukaemia.
Schott, G. and Sperling, C. and Schrappe, M. and Ratei, R. and Martin, M. and Meyer, U. and Riehm, H. and Ludwig, W.D.
British Journal of Haematology 101 : 753-755. 1 January 1998

New insights into the biology of Philadelphia-chromosome-positive acute lymphoblastic leukaemia using a combination of May-Grunwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level.
Haferlach, T. and Winkemann, M. and Ramm-Petersen, L. and Meeder, M. and Schoch, R. and Weber-Matthiesen, K. and Schlegelberger, B. and Schoch, C. and Ludwig, W.D. and Hiddemann, W. and Loffler, H.
British Journal of Haematology 99 : 452-459. 1 November 1997

Morphological and cytochemical findings in 150 cases of T-lineage acute lymphoblastic leukemia in adults.
Gassmann, W. and Loeffler, H. and Thiel, E. and Ludwig, W.D. and Schwartz, S. and Haferlach, T. and Maurer, J. and Rieder, H. and Fonatsch, C. and Goekbuget, N. and Hoelzer, D.
British Journal of Haematology 97 : 372-382. 1 January 1997

Expression of intercellular adhesion molecule 1 (ICAM-1) in childhood acute lymphoblastic leukemia: correlation with clinical features and outcome.
Mielcarek, M. and Sperling, C. and Schrappe, M. and Meyer, U. and Riehm, H. and Ludwig, W.D.
British Journal of Haematology 96 : 301-307. 1 January 1997

Prognostic significance of additional chromosome abnormalities in adult patients with philadelphia chromosome positive acute lymphoblastic leukaemia.
Rieder, H. and Ludwig, W.D. and Gassmann, W. and Maurer, J. and Janssen, J.W. and Gokbuget, N. and Schwartz, S. and Thiel, E. and Loeffler, H. and Bartram, C.R. and Hoelzer, D. and Fonatsch, C.
British Journal of Haematology 95 : 678-691. 1 January 1997

Acute myeloid and T-cell acute lymphoblastic leukaemia with aberrant antigen expression exhibit similar TCRdelta gene rearrangements.
Schmidt, C.A. and Przybylski, G. and Tietze, A. and Oettle, H. and Siegert, W. and Ludwig, W.D.
British Journal of Haematology 92 (4): 929-936. 1 January 1996

Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, fish and fiction studies.
Zhao, Y.M. and Poetsch, M. and Weber-Matthiesen, K. and Rohde, G. and Winkemann, M. and Haferlach, T. and Gassmann, W. and Ludwig, W.D. and Grote, W. and Loeffler, H. and Schlegelberger, B.
British Journal of Haematology 92 (3): 673-680. 1 January 1996

The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event.
Janssen, J.W. and Ridge, S.A. and Papadopoulos, P. and Cotter, F. and Ludwig, W.D. and Fonatsch, C. and Rieder, H. and Ostertag, W. and Bartram, C.R. and Wiedemann, L.M.
British Journal of Haematology 90 (1): 222-224. 1 January 1995

Molecular characterization of illegitimate TCRdelta gene rearrangements in acute myeloid leukaemia.
Przybylski, G. and Oettle, H. and Ludwig, W.D. and Siegert, W. and Schmidt, C.A.
British Journal of Haematology 87 : 301-307. 1 January 1994

Detection of herpesvirus type 6 by polymerase chain reaction in blood donors: random tests and prospective longitudinal studies.
Wilborn, F. and Schmidt, C.A. and Zimmermann, R. and Brinkmann, V. and Neipel, F. and Siegert, W.
British Journal of Haematology 88 : 187-192. 1 January 1994

Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases.
Foss, H.D. and Herbst, H. and Oelmann, E. and Samol, J. and Grebe, M. and Blankenstein, T. and Matthes, J. and Qin, Z. and Falini, B. and Pileri, S. and Diamantstein, T. and Stein, H.
British Journal of Haematology 84 (4): 627-635. 1 August 1993

Letter

Expression of CD274 (PD-L1) is associated with unfavourable recurrent mutations in AML.
Zajac, M. and Zaleska, J. and Dolnik, A. and Bullinger, L. and Giannopoulos, K.
British Journal of Haematology 183 (5): 822-825. December 2018

Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
Dang, N.H. and Ogura, M. and Castaigne, S. and Fayad, L.E. and Jerkeman, M. and Radford, J. and Pezzutto, A. and Bondarenko, I. and Stewart, D.A. and Shnaidman, M. and Sullivan, S. and Vandendries, E. and Tobinai, K. and Ramchandren, R. and Hamlin, P.A. and Giné, E. and Ando, K.
British Journal of Haematology 182 (4): 583-586. August 2018

BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines.
Ullrich, K. and Wurster, K.D. and Lamprecht, B. and Koechert, K. and Engert, A. and Doerken, B. and Janz, M. and Mathas, S.
British Journal of Haematology 155 (3): 398-402. November 2011

Monitoring oral anticoagulant therapy in patients with lupus anticoagulants.
Ortel, T.L. and Moll, S.
British Journal of Haematology 101 : 390-392. 1 May 1998

CD34 expression in de novo acute myeloid leukaemia.
Sperling, C. and Buechner, T. and Sauerland, C. and Fonatsch, C. and Thiel, E. and Ludwig, W.D.
British Journal of Haematology 85 : 635-637. 1 January 1993